Rewalk Robotics (NASDAQ:RWLK) posted its quarterly earnings data on Thursday. The medical device company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.01, Morningstar.com reports. Rewalk Robotics had a negative net margin of 365.87% and a negative return on equity of 3,654.32%. The company had revenue of $1.62 million for the quarter, compared to the consensus estimate of $2.12 million. Rewalk Robotics updated its FY 2018 guidance to EPS.
NASDAQ RWLK remained flat at $$0.67 on Friday. 433,778 shares of the company were exchanged, compared to its average volume of 191,463. The company has a market capitalization of $25.92 million, a PE ratio of -0.68 and a beta of 0.77. Rewalk Robotics has a twelve month low of $0.65 and a twelve month high of $1.60.
Several research firms have recently issued reports on RWLK. Zacks Investment Research upgraded shares of Rewalk Robotics from a “hold” rating to a “buy” rating and set a $1.25 price objective on the stock in a report on Thursday, August 30th. Oppenheimer set a $2.00 price objective on shares of Rewalk Robotics and gave the stock a “buy” rating in a report on Friday, August 24th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $1.85.
COPYRIGHT VIOLATION WARNING: This news story was first reported by Macon Daily and is owned by of Macon Daily. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://macondaily.com/2018/11/10/rewalk-robotics-rwlk-posts-quarterly-earnings-results-beats-estimates-by-0-01-eps.html.
About Rewalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.
Recommended Story: S&P 500 Index
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.